Moreover, concomitant Treg cell expansion induced by CD25-biased IL-2cx/IC may lead to suppression of tumor-specific CD8+ T cells, particularly once the concentration of IL-2cx/IC decreases and the CD8+ T cells cannot effectively compete for circulating IL-2. The gene discussed is IL2; the disease is neoplasm.